How Psychedelics Are Being Marketed to Ordinary Swedes
Translated from Swedish, summarized and contextualized by DistantNews.
TLDR
- Ann-Marie, a Swedish woman struggling with depression and anxiety, sought treatment at a psychedelic retreat in the Netherlands.
- The retreat, organized by the Swedish company Nysnรถ, cost 40,000 SEK and focused on 'transformative processes' rather than symptom relief.
- The article explores the growing interest in psychedelics as a treatment for mental health issues and the increasing investment in this field.
Svenska Dagbladet delves into the burgeoning world of psychedelic therapy, a topic that has rapidly shifted from the fringes of counterculture to the forefront of mental health innovation. Our report follows Ann-Marie, a seemingly ordinary Swede, on her journey to a retreat in the Netherlands, seeking solace from a lifelong battle with depression and anxiety.
I don't like it when it gets too fuzzy. Because many people are a bit fuzzy. It's two fuzzy people sitting and fuzzing about it. And then I feel that it doesn't appeal to me. I want it to be scientific. It should be sterile and it should be... maybe a little boring if you say so.
This isn't just a personal story; it reflects a broader societal trend. Psychedelics, once stigmatized as dangerous drugs, are now being presented as a cutting-edge treatment, attracting significant investment and scientific research. Ann-Marie's choice to spend 40,000 SEK on this experience with Nysnรถ highlights the desperation many feel when conventional treatments fall short. She seeks not just symptom relief, but 'transformative processes' โ a desire for profound, life-altering change.
When you say treatment, you mean something targeted to relieve symptoms. For us, it is important to clarify that it is not about that, but that it is transformative processes. That is, life-changing experiences, which go beyond symptom relief.
From a Swedish perspective, this exploration is particularly interesting. While the scientific community globally is investigating these substances, the practical application, especially for profit, raises questions. Nysnรถ's emphasis on 'transformative processes' over 'symptom relief' suggests a nuanced approach, but the high cost and the use of a 'narcotics-classified substance' in a foreign country will undoubtedly spark debate within Sweden about regulation, accessibility, and the ethical considerations of such treatments. SvD aims to provide a balanced view, exploring both the potential benefits and the inherent complexities of this rapidly evolving field.
You don't just send people down and take some drugs. That's not what this is, but this is...
Originally published by Svenska Dagbladet in Swedish. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.